B Lymphoblastic Leukemia clinical trials

Explore recruiting b lymphoblastic leukemia clinical trials.

Recruiting b lymphoblastic leukemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

B Lymphoblastic Leukemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

HOVON 146 ALL: Blinatumomab added to prephase and consolidation therapy in precursor B-acute lymphoblastic leukemia in adults. A phase II trial.

Belgium, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Application of antiCD19 CAR T lymphocytes for the treatment of adult patients with B-cell acute lymphoblastic leukemia with resistance, relapse or detectable measurable residual disease. Phase I/II clinical trial (MERMAID1)

Poland

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

An open label multicenter phase II study to investigate the efficacy, safety and tolerability of the Obe-cel in patients with minimal residual disease (MRD) of Philadelphia negative (Ph neg) B-precursor acute lymphoblastic leukaemia (B-ALL) - GMALL-OBECEL

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

B Lymphoblastic Leukemia trials by city

B Lymphoblastic Leukemia in Toronto B Lymphoblastic Leukemia in Vancouver B Lymphoblastic Leukemia in Montreal B Lymphoblastic Leukemia in Calgary B Lymphoblastic Leukemia in Edmonton B Lymphoblastic Leukemia in Ottawa B Lymphoblastic Leukemia in Winnipeg B Lymphoblastic Leukemia in Quebec City B Lymphoblastic Leukemia in Hamilton B Lymphoblastic Leukemia in Kitchener B Lymphoblastic Leukemia in London B Lymphoblastic Leukemia in Halifax B Lymphoblastic Leukemia in New York B Lymphoblastic Leukemia in Los Angeles B Lymphoblastic Leukemia in Chicago B Lymphoblastic Leukemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease